RELATIONSHIP BETWEEN PARAMETERS OF SEROTONIN TRANSPORT AND ANTIDEPRESSANT PLASMA-LEVELS OR THERAPEUTIC RESPONSE IN DEPRESSIVE PATIENTS TREATED WITH PAROXETINE AND AMITRIPTYLINE

被引:29
作者
KUHS, H [1 ]
SCHLAKE, HP [1 ]
ROLF, LH [1 ]
RUDOLF, GAE [1 ]
机构
[1] UNIV MUNSTER,DEPT NEUROL,W-4400 MUNSTER,GERMANY
关键词
PAROXETINE; AMITRIPTYLINE; SEROTONIN;
D O I
10.1111/j.1600-0447.1992.tb10320.x
中图分类号
R749 [精神病学];
学科分类号
100205 [精神病与精神卫生学];
摘要
In a double-blind clinical study, antidepressant plasma levels, parameters of platelet serotonin (5-HT) transport (K(m), V(max) and basal platelet 5-HT content) and therapeutic response were measured in depressive patients treated with either paroxetine (30 mg/day) or amitriptyline (150 mg/day) for 6 weeks. No correlation could be found between paroxetine plasma levels and therapeutic outcome after 2, 4 and 6 weeks of treatment. In contrast to the amitriptyline group, a marked increase in K(m) from baseline to week 2 was determined in paroxetine-treated patients, with K(m) increase being correlated with paroxetine plasma levels at week 2. However, no significant relationship could be found between 5-HT transport parameters and any of the outcome measures in either treatment group.
引用
收藏
页码:364 / 369
页数:6
相关论文
共 27 条
[1]
EFFECTS OF ZIMELIDINE AND DESIPRAMINE ON SEROTONIN AND NORADRENALINE UPTAKE MECHANISMS IN RELATION TO PLASMA-CONCENTRATIONS AND TO THERAPEUTIC EFFECTS DURING TREATMENT OF DEPRESSION [J].
ABERGWISTEDT, A ;
JOSTELL, KG ;
ROSS, SB ;
WESTERLUND, D .
PSYCHOPHARMACOLOGY, 1981, 74 (04) :297-305
[2]
EFFECTS OF AMOXAPINE ON SEROTONIN UPTAKE IN HUMAN-BLOOD PLATELETS OF DEPRESSED-PATIENTS AND NORMAL CONTROLS [J].
ARORA, RC ;
MELTZER, HY .
PSYCHIATRY RESEARCH, 1983, 9 (01) :29-36
[3]
AN EARLY CLINICAL PHASE-II EVALUATION OF PAROXETINE, A NEW POTENT AND SELECTIVE 5HT-UPTAKE INHIBITOR IN PATIENTS WITH DEPRESSIVE-ILLNESS [J].
BORUP, C ;
MEIDAHL, B ;
PETERSEN, IM ;
VANGTORP, A ;
HONORE, PL .
PHARMACOPSYCHIATRIA, 1982, 15 (06) :183-186
[4]
REDUCTION OF WHOLE-BLOOD SEROTONIN IN DEPRESSED-PATIENTS TREATED WITH A NEW, SELECTIVE SEROTONIN-UPTAKE INHIBITOR, FEMOXETINE [J].
BORUP, C ;
PETERSEN, IM ;
LEFEVREHONORE, P ;
WETTERBERG, L .
PSYCHOPHARMACOLOGY, 1979, 63 (03) :241-243
[5]
DETERMINATION OF PAROXETINE IN HUMAN-PLASMA, USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
BRETT, MA ;
DIERDORF, HD ;
ZUSSMAN, BD ;
COATES, PE .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 419 :438-444
[6]
INHIBITION OF 5-HYDROXYTRYPTAMINE REUPTAKE BY AMITRIPTYLINE AND ZIMELIDINE AND ITS RELATIONSHIP TO THEIR THERAPEUTIC ACTION [J].
COPPEN, A ;
RAO, VAR ;
SWADE, C ;
WOOD, K .
PSYCHOPHARMACOLOGY, 1979, 63 (02) :125-129
[7]
BIOCHEMISTRY OF AFFECTIVE DISORDERS [J].
COPPEN, A .
BRITISH JOURNAL OF PSYCHIATRY, 1967, 113 (504) :1237-+
[8]
A RATING SCALE FOR DEPRESSION [J].
HAMILTON, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62
[9]
HEALY D, 1984, PSYCHOPATHOLOGY, V7, P82
[10]
A PHARMACOKINETIC DOSE TITRATION STUDY IN ADULT AND ELDERLY DEPRESSED-PATIENTS [J].
HEBENSTREIT, GF ;
FELLERER, K ;
ZOCHLING, R ;
ZENTZ, A ;
DUNBAR, GC .
ACTA PSYCHIATRICA SCANDINAVICA, 1989, 80 :81-84